Oral Anticoagulation in Atrial Fibrillation: Are the Problems Solved?
Yükleniyor...
Dosyalar
Tarih
2010
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
The prevalence of atrial fibrillation (AF) is high and it is expected to increase in the near future (1). AF is a strong independent risk factor for ischemic stroke and systemic arterial embolisation (2). Oral anticoagulation (OAC) has been shown to decrease the risk of stroke. In a meta-analysis of 6 randomized trials including 2900 participants, the estimated relative risk reduction is reported as 64% (3). Despite the evident benefits, OAC is underused even in high risk AF patients (4, 5).
[Abstract not Available]
[Abstract not Available]
Açıklama
Anahtar Kelimeler
Kalp ve Kalp Damar Sistemi
Kaynak
Anadolu Kardiyoloji Dergisi
WoS Q Değeri
N/A
Scopus Q Değeri
Cilt
10
Sayı
Künye
Doğan, U., (2010). Oral Anticoagulation in Atrial Fibrillation: Are the Problems Solved?. Anadolu Kardiyoloji Dergisi, (10), 41-42. Doi: 10.5152/akd.2010.009
